Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-12-12

FDA Approved: TASIMELTEON — Original Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved tasimelteon under an original application for Teva Pharmaceuticals for the treatment of non-24-hour sleep-wake rhythm disorder in totally blind ind…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tasimelteon (tasimelteon)

Snippet

ORIG AP for TASIMELTEON (TASIMELTEON)